These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27990610)

  • 41. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface markers of hepatocellular cancer stem cells and their clinical potential.
    Feng D; Wang N; Hu J; Li W
    Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
    Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.
    Chan LH; Luk ST; Ma S
    Mol Cells; 2015 Mar; 38(3):202-9. PubMed ID: 25666349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.
    Machida K; Feldman DE; Tsukamoto H
    Adv Exp Med Biol; 2015; 815():131-44. PubMed ID: 25427905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
    Matthai SM; Ramakrishna B
    Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunology of cancer stem cells in solid tumours. A review.
    Maccalli C; Volontè A; Cimminiello C; Parmiani G
    Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.
    Holczbauer Á; Factor VM; Andersen JB; Marquardt JU; Kleiner DE; Raggi C; Kitade M; Seo D; Akita H; Durkin ME; Thorgeirsson SS
    Gastroenterology; 2013 Jul; 145(1):221-231. PubMed ID: 23523670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.
    Machida K
    Adv Exp Med Biol; 2018; 1032():105-113. PubMed ID: 30362094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver stem cells and hepatocellular carcinoma.
    Mishra L; Banker T; Murray J; Byers S; Thenappan A; He AR; Shetty K; Johnson L; Reddy EP
    Hepatology; 2009 Jan; 49(1):318-29. PubMed ID: 19111019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of Hepatic Cancer Stem Cells.
    Sukowati CHC
    Adv Exp Med Biol; 2019; 1139():59-81. PubMed ID: 31134495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.
    Lee TK; Guan XY; Ma S
    Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):26-44. PubMed ID: 34504325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HCV and tumor-initiating stem-like cells.
    Machida K
    Front Physiol; 2022; 13():903302. PubMed ID: 36187761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.
    Mohan A; Raj Rajan R; Mohan G; Kollenchery Puthenveettil P; Maliekal TT
    Front Cell Dev Biol; 2021; 9():668851. PubMed ID: 34150761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer stem cells and immunoresistance: clinical implications and solutions.
    Codony-Servat J; Rosell R
    Transl Lung Cancer Res; 2015 Dec; 4(6):689-703. PubMed ID: 26798578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.